HomeCompareRGTPQ vs PLD

RGTPQ vs PLD: Dividend Comparison 2026

RGTPQ yields 1250.00% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RGTPQ wins by $135327071.68M in total portfolio value
10 years
RGTPQ
RGTPQ
● Live price
1250.00%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$135327077.59M
Annual income
$116,926,161,071,848.38
Full RGTPQ calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — RGTPQ vs PLD

📍 RGTPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRGTPQPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RGTPQ + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RGTPQ pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGTPQ
Annual income on $10K today (after 15% tax)
$106,250.00/yr
After 10yr DRIP, annual income (after tax)
$99,387,236,911,071.11/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, RGTPQ beats the other by $99,387,232,872,954.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGTPQ + PLD for your $10,000?

RGTPQ: 50%PLD: 50%
100% PLD50/50100% RGTPQ
Portfolio after 10yr
$67663541.75M
Annual income
$58,463,082,911,286.78/yr
Blended yield
86.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

RGTPQ
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGTPQ buys
0
PLD buys
0
No recent congressional trades found for RGTPQ or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRGTPQPLD
Forward yield1250.00%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$135327077.59M$5.91M
Annual income after 10y$116,926,161,071,848.38$4,750,725.19
Total dividends collected$133960810.96M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RGTPQ vs PLD ($10,000, DRIP)

YearRGTPQ PortfolioRGTPQ Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$135,700$125,000.00$11,241$540.96+$124.5KRGTPQ
2$1,730,479$1,585,280.37$13,019$991.13+$1.72MRGTPQ
3$20,744,959$18,893,346.29$15,801$1,870.97+$20.73MRGTPQ
4$233,872,934$211,675,827.14$20,609$3,701.21+$233.85MRGTPQ
5$2,480,500,804$2,230,256,765.05$29,919$7,867.97+$2480.47MRGTPQ
6$24,761,170,753$22,107,034,892.35$50,631$18,617.74+$24761.12MRGTPQ
7$232,737,122,500$206,242,669,794.36$105,528$51,352.20+$232737.02MRGTPQ
8$2,060,741,008,119$1,811,712,287,044.72$287,364$174,449.42+$2060740.72MRGTPQ
9$17,197,118,239,637$14,992,125,360,949.39$1,081,760$774,280.77+$17197117.16MRGTPQ
10$135,327,077,588,260$116,926,161,071,848.38$5,908,209$4,750,725.19+$135327071.68MRGTPQ

RGTPQ vs PLD: Complete Analysis 2026

RGTPQStock

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

Full RGTPQ Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this RGTPQ vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGTPQ vs SCHDRGTPQ vs JEPIRGTPQ vs ORGTPQ vs KORGTPQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.